European journal of ophthalmology · 1998
Effects of 0.5% and 0.25% apraclonidine on postoperative intraocular hypertension after cataract extraction.
Клиническое исследованиеСравнительное исследованиеСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Simşek S, Demirok A, Yaşar T, Cinal A, Bayram A, Yilmaz O F
Аннотация
PURPOSE: We conducted a double-masked, prospective study to evaluate the effect of 0.5% and 0.25% apraclonidine on postoperative intraocular pressure (IOP) in patients undergoing extracapsular cataract extraction (ECCE) with intraocular lens (IOL) implantation.
METHODS: Fifty-four patients scheduled for ECCE were randomly divided into three groups of 18. The first group received one drop of 0.50% apraclonidine topically one hour before surgery and immediately after the end of the procedure. The second group received the same regimen but with 0.25% apraclonidine. The third group received artificial tears as the control group. IOP was measured 12 h preoperatively and 6 and 24 h postoperatively. All the measurements were made using the same Goldmann applanation tonometer by the same surgeon who did not know to which group the patient belonged.
RESULTS: Preoperative mean IOP was 13.66 +/- 2.76 mmHg in the first group, 14.27 +/- 2.24 mmHg in the second and 14.5 +/- 1.34 mmHg in the control group. The differences were not significant (p = 0.398). Mean IOP at the early postoperative visit (6 h) was significantly lower in the first group (17.44 +/- 4.95 mmHg) than the second (21.78 +/- 7.19 mmHg) and the control group (24.55 +/- 5.65 mmHg) (p < 0.001). Mean postoperative IOP at 24 h was again significantly lower in the first group (14.33 +/- 3.75 mmHg) than the second (17.11 +/- 4.16 mmHg) and the control group (19.61 +/- 3.20 mmHg) (p, 0.001).
CONCLUSIONS: Our findings indicate that topical 0.5% apraclonidine controlled early postoperative intraocular hypertension after cataract extraction without any side effects, while the 0.25% drops were not effective.
METHODS: Fifty-four patients scheduled for ECCE were randomly divided into three groups of 18. The first group received one drop of 0.50% apraclonidine topically one hour before surgery and immediately after the end of the procedure. The second group received the same regimen but with 0.25% apraclonidine. The third group received artificial tears as the control group. IOP was measured 12 h preoperatively and 6 and 24 h postoperatively. All the measurements were made using the same Goldmann applanation tonometer by the same surgeon who did not know to which group the patient belonged.
RESULTS: Preoperative mean IOP was 13.66 +/- 2.76 mmHg in the first group, 14.27 +/- 2.24 mmHg in the second and 14.5 +/- 1.34 mmHg in the control group. The differences were not significant (p = 0.398). Mean IOP at the early postoperative visit (6 h) was significantly lower in the first group (17.44 +/- 4.95 mmHg) than the second (21.78 +/- 7.19 mmHg) and the control group (24.55 +/- 5.65 mmHg) (p < 0.001). Mean postoperative IOP at 24 h was again significantly lower in the first group (14.33 +/- 3.75 mmHg) than the second (17.11 +/- 4.16 mmHg) and the control group (19.61 +/- 3.20 mmHg) (p, 0.001).
CONCLUSIONS: Our findings indicate that topical 0.5% apraclonidine controlled early postoperative intraocular hypertension after cataract extraction without any side effects, while the 0.25% drops were not effective.